Free Trial

IMAC (IMAC) Competitors

IMAC logo
$0.04 +0.00 (+8.11%)
As of 04/25/2025

IMAC vs. XWEL, MNDR, NUWE, OGEN, SXTP, RSLS, CANF, SNES, ACON, and TIVC

Should you be buying IMAC stock or one of its competitors? The main competitors of IMAC include XWELL (XWEL), Mobile-health Network Solutions (MNDR), Nuwellis (NUWE), Oragenics (OGEN), 60 Degrees Pharmaceuticals (SXTP), ReShape Lifesciences (RSLS), Can-Fite BioPharma (CANF), SenesTech (SNES), Aclarion (ACON), and Tivic Health Systems (TIVC). These companies are all part of the "medical" sector.

IMAC vs.

XWELL (NASDAQ:XWEL) and IMAC (NASDAQ:IMAC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, community ranking, dividends, analyst recommendations, institutional ownership and media sentiment.

In the previous week, IMAC had 1 more articles in the media than XWELL. MarketBeat recorded 3 mentions for IMAC and 2 mentions for XWELL. XWELL's average media sentiment score of 0.96 beat IMAC's score of -0.16 indicating that XWELL is being referred to more favorably in the media.

Company Overall Sentiment
XWELL Positive
IMAC Neutral

XWELL has a net margin of -46.82% compared to IMAC's net margin of -75.40%. IMAC's return on equity of -52.17% beat XWELL's return on equity.

Company Net Margins Return on Equity Return on Assets
XWELL-46.82% -88.27% -43.24%
IMAC -75.40%-52.17%-34.51%

IMAC has lower revenue, but higher earnings than XWELL.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XWELL$33.90M0.12-$27.74M-$3.62-0.21
IMAC$15.22M0.07-$10.54MN/AN/A

IMAC received 68 more outperform votes than XWELL when rated by MarketBeat users. However, 75.00% of users gave XWELL an outperform vote while only 60.17% of users gave IMAC an outperform vote.

CompanyUnderperformOutperform
XWELLOutperform Votes
3
75.00%
Underperform Votes
1
25.00%
IMACOutperform Votes
71
60.17%
Underperform Votes
47
39.83%

8.7% of XWELL shares are owned by institutional investors. Comparatively, 24.3% of IMAC shares are owned by institutional investors. 8.8% of XWELL shares are owned by insiders. Comparatively, 10.0% of IMAC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

XWELL has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500. Comparatively, IMAC has a beta of -0.88, suggesting that its share price is 188% less volatile than the S&P 500.

Summary

IMAC beats XWELL on 7 of the 13 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMAC vs. The Competition

MetricIMACSpecialty Outpatient Clinics IndustryMedical SectorNASDAQ Exchange
Market Cap$1.06M$932,000.00$5.57B$7.83B
Dividend YieldN/AN/A5.11%4.22%
P/E RatioN/AN/A22.4418.48
Price / Sales0.070.07394.09103.59
Price / CashN/AN/A38.1834.62
Price / Book0.060.066.774.25
Net Income-$10.54M-$10.54M$3.22B$248.23M
7 Day PerformanceN/AN/A1.49%0.89%
1 Month PerformanceN/AN/A4.00%3.53%
1 Year PerformanceN/AN/A16.21%5.08%

IMAC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMAC
IMAC
N/A$0.04
+8.1%
N/A-98.9%$1.06M$15.22M0.00106Gap Up
XWEL
XWELL
1.2404 of 5 stars
$0.80
+2.7%
N/A-57.2%$4.20M$33.90M-0.22360Short Interest ↓
MNDR
Mobile-health Network Solutions
N/A$1.44
+0.7%
N/A-99.2%$4.16M$13.97M0.00N/ANews Coverage
Negative News
Gap Down
NUWE
Nuwellis
3.0495 of 5 stars
$0.95
-5.0%
$17.00
+1,689.5%
-81.7%$4.16M$8.74M-0.0170Short Interest ↓
Gap Down
OGEN
Oragenics
N/A$0.19
-2.7%
N/A-82.0%$4.12M$40,000.00-0.035Analyst Forecast
News Coverage
Negative News
SXTP
60 Degrees Pharmaceuticals
0.4734 of 5 stars
$2.79
-5.4%
N/A+133.2%$4.11M$607,574.00-0.283
RSLS
ReShape Lifesciences
0.4501 of 5 stars
$0.36
-0.8%
N/A-96.5%$4.08M$8.01M-0.0350Short Interest ↑
Negative News
Gap Up
CANF
Can-Fite BioPharma
1.6584 of 5 stars
$1.15
+1.8%
$14.00
+1,117.4%
-47.3%$4.07M$674,000.00-0.648Gap Up
SNES
SenesTech
2.7706 of 5 stars
$2.27
flat
$10.00
+340.5%
-70.4%$4.03M$1.86M-0.2330Upcoming Earnings
Short Interest ↓
Gap Down
ACON
Aclarion
1.5023 of 5 stars
$6.84
-8.9%
$11,758.50
+171,807.9%
-99.8%$3.98M$45,724.000.007Short Interest ↑
News Coverage
TIVC
Tivic Health Systems
0.1762 of 5 stars
$6.47
-9.1%
N/A-75.3%$3.97M$780,000.000.0010Short Interest ↑
Gap Down

Related Companies and Tools


This page (NASDAQ:IMAC) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners